Zobrazeno 1 - 10
of 185
pro vyhledávání: '"Geoffrey, Falkson"'
Publikováno v:
American Journal of Clinical Oncology. 30:113-125
OBJECTIVE The objective of this multicenter phase III trial was to study the impact on time to treatment failure (TTF) and survival of cyclophosphamide, Adriamycin, and 5-fluorouracil (CAF) versus CAF/thiotepa, Adriamycin, vinblastine, and Halotestin
Autor:
Susan L. Beck, Geoffrey Falkson
Publikováno v:
Pain. 94:75-84
Inadequate relief from cancer pain is an international health problem. The aim of this study was to document the prevalence and patterns of cancer pain management in the Republic of South Africa. The first phase of this study consisted of screening 2
Autor:
Chih Hung Chang, Sonya Eremenco, M. Mertz, Carla I. Falkson, L Lent, David Cella, Geoffrey Falkson, V. Mullin
Publikováno v:
Quality of Life Research. 9:139-149
This pilot study investigated the feasibility of translating a quality of life instrument, the Functional Assessment of Cancer Therapy – General version (FACT-G) and the breast cancer version (FACT-B), which consists of the FACT-G plus 10 additiona
Autor:
Donna Neuberg, Melvyn P. Richter, John E. Olson, Kennedy W. Gilchrist, Lawrence J. Solin, Geoffrey Falkson, Kishan J. Pandya, Michael H. Veeder, Douglass C. Tormey
Publikováno v:
Cancer. 79:1138-1149
BACKGROUND The purpose of this study was to test the role of radiotherapy following total mastectomy, axillary dissection, and adjuvant systemic therapy in the management of operable locally advanced breast carcinoma. METHODS After undergoing mastect
Publikováno v:
International Journal of Gynecological Cancer. 7:158-162
The objective of this study was to evaluate cisplatin plus ifosfamide as neoadjuvant chemotherapy with regard to toxicity and clinical response in patients with stage IIB cervical cancer. Sixty-eight patients with previously untreated stage IIB cervi
Publikováno v:
Investigational New Drugs. 14:391-394
The aim of this study was to investigate the possible therapeutic effect of 13-cis-retinoic acid plus interferon alpha-2a in patients with inoperable squamous cancer of the esophagus. Patients with advanced, measurable, histologically confirmed squam
Publikováno v:
American Journal of Clinical Oncology. 18:287-292
This study was undertaken to investigate the response rate, time to treatment failure and survival time of patients with hepatocellular cancer (HCC) treated with beta-interferon or menogaril. Sixty-nine patients with histologically confirmed, advance
Autor:
C Holcroft, J Wolter, Frank J. Cummings, Geoffrey Falkson, Rebecca Gelman, Douglass C. Tormey
Publikováno v:
Journal of Clinical Oncology. 13:1453-1458
PURPOSE To investigate the long-term survival of premenopausal women with previously untreated first recurrence or metastases of breast cancer entered on Eastern Cooperative Oncology Group (ECOG) study 2177 (EST 2177), which completed accrual in June
Publikováno v:
Investigational New Drugs. 12:251-254
Fotemustine is a novel chloroethylnitrosourea, that readily penetrates the blood brain barrier. Preliminary French studies reported encouraging results with fotemustine in patients with cerebral metastases of malignant melanoma. Thirty-one patients w
Publikováno v:
Journal of Clinical Oncology. 12:1535-1540
PURPOSE The aim of this study was to evaluate the efficacy and toxicity of gemcitabine at higher doses than had been used previously in patients with non-small-cell lung cancer (NSCLC). PATIENTS AND METHODS Eighty-four patients (65 men, 19 women; age